Free Trial

iRhythm Technologies (IRTC) Competitors

iRhythm Technologies logo
$137.00 +3.08 (+2.30%)
Closing price 04:00 PM Eastern
Extended Trading
$136.94 -0.06 (-0.04%)
As of 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRTC vs. SOLV, SNN, PEN, STVN, GKOS, BLCO, NARI, TMDX, SLNO, and INSP

Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

iRhythm Technologies vs. Its Competitors

Solventum (NYSE:SOLV) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Solventum has a net margin of 4.55% compared to iRhythm Technologies' net margin of -15.90%. Solventum's return on equity of 31.01% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Solventum4.55% 31.01% 6.53%
iRhythm Technologies -15.90%-101.04%-9.55%

In the previous week, iRhythm Technologies had 3 more articles in the media than Solventum. MarketBeat recorded 12 mentions for iRhythm Technologies and 9 mentions for Solventum. Solventum's average media sentiment score of 0.87 beat iRhythm Technologies' score of 0.67 indicating that Solventum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
iRhythm Technologies
5 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Solventum presently has a consensus target price of $84.38, indicating a potential upside of 15.58%. iRhythm Technologies has a consensus target price of $137.30, indicating a potential upside of 0.22%. Given Solventum's higher probable upside, analysts clearly believe Solventum is more favorable than iRhythm Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27
iRhythm Technologies
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90

Solventum has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.

Solventum has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solventum$8.25B1.53$478M$2.1633.80
iRhythm Technologies$591.84M7.39-$113.29M-$3.14-43.63

Summary

Solventum beats iRhythm Technologies on 8 of the 13 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRTC vs. The Competition

MetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.28B$1.99B$5.57B$9.31B
Dividend YieldN/AN/A4.23%4.03%
P/E RatioN/A34.3428.6119.73
Price / Sales7.3915.07412.31173.11
Price / CashN/A54.7436.0257.96
Price / Book47.248.638.235.67
Net Income-$113.29M-$62.39M$3.23B$257.79M
7 Day Performance3.10%-1.66%-0.01%0.52%
1 Month Performance-5.39%10.22%5.61%8.84%
1 Year Performance30.53%3.79%26.52%14.18%

iRhythm Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRTC
iRhythm Technologies
1.0172 of 5 stars
$137.00
+2.3%
$137.30
+0.2%
+35.8%$4.28B$591.84M0.002,000Analyst Forecast
SOLV
Solventum
0.7277 of 5 stars
$76.24
-2.9%
$81.50
+6.9%
+52.8%$13.58B$8.25B14.3822,000Analyst Upgrade
SNN
Smith & Nephew SNATS
2.8855 of 5 stars
$29.95
-1.1%
$28.00
-6.5%
+5.9%$13.26B$5.81B13.8717,349
PEN
Penumbra
4.7411 of 5 stars
$248.05
-1.2%
$302.40
+21.9%
+23.4%$9.72B$1.19B234.014,500
STVN
Stevanato Group
N/A€24.23
-1.5%
N/A+21.0%€7.34B€1.19B47.515,521Positive News
GKOS
Glaukos
4.3346 of 5 stars
$101.69
-1.7%
$134.67
+32.4%
-20.2%$5.91B$383.48M-42.91780Analyst Forecast
BLCO
Bausch + Lomb
3.0202 of 5 stars
$13.83
-0.4%
$15.54
+12.4%
-13.4%$4.91B$4.79B28.9213,500
NARI
Inari Medical
0.2605 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
TMDX
TransMedics Group
2.2586 of 5 stars
$125.17
-3.1%
$127.33
+1.7%
-19.9%$4.37B$441.54M94.99210Positive News
Analyst Forecast
SLNO
Soleno Therapeutics
4.5906 of 5 stars
$85.27
-1.6%
$107.10
+25.6%
+66.5%$4.37BN/A-18.4630
INSP
Inspire Medical Systems
4.8607 of 5 stars
$127.11
-1.1%
$211.91
+66.7%
-7.8%$3.79B$802.80M59.211,246Positive News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:IRTC) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners